122 related articles for article (PubMed ID: 2943916)
1. [Thrombosis in various diseases: myeloproliferative disorders].
Niikura H
Nihon Rinsho; 1986 May; 44(5):1144-52. PubMed ID: 2943916
[No Abstract] [Full Text] [Related]
2. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
[No Abstract] [Full Text] [Related]
3. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
Viero P; Cortelazzo S; Barbui T
Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
[No Abstract] [Full Text] [Related]
4. The value of beta TG/PF4 ratio in patients with high platelet count.
Fabris F; Luzzatto G; Girolami A
Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
[No Abstract] [Full Text] [Related]
5. Platelet-specific proteins in myeloproliferative disorders.
Luzzatto G; Cella G
Acta Haematol; 1992; 87(4):216-7. PubMed ID: 1387757
[No Abstract] [Full Text] [Related]
6. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
[No Abstract] [Full Text] [Related]
7. [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].
Craveri A; Lanfredini M; Tornaghi G; Frangione A; Milella AM; Ranieri R; Tonali M; Gatti L; Franco G; Moia M
G Clin Med; 1980 Nov; 61(11):812-21. PubMed ID: 6165639
[No Abstract] [Full Text] [Related]
8. [Hemostasis disorders and their treatment in patients with chronic myeloproliferative diseases].
Sidorova LD; Arkhipov BF; Degtiareva MM; Barkagan LZ
Ter Arkh; 1981; 53(9):91-5. PubMed ID: 7302866
[No Abstract] [Full Text] [Related]
9. Platelet specific proteins in Bernard-Soulier syndrome.
Devaraj R; Prowse C; Dawes J; Toolis F
Thromb Haemost; 1979 Dec; 42(4):1349. PubMed ID: 94471
[No Abstract] [Full Text] [Related]
10. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
Luzzatto G; Fabris F; Mazzucato M; Girolami A
Scand J Haematol; 1985 Sep; 35(3):299-304. PubMed ID: 2414843
[TBL] [Abstract][Full Text] [Related]
11. Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units.
Stratta P; Canavese C; Peiretti F; Vallauri P; Vercellone A
Thromb Haemost; 1983 Feb; 49(1):61. PubMed ID: 6189235
[No Abstract] [Full Text] [Related]
12. Platelet activation and allergic asthma.
Gresele P; Todisco T; Merante F; Nenci GG
N Engl J Med; 1982 Mar; 306(9):549. PubMed ID: 6173752
[No Abstract] [Full Text] [Related]
13. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets.
McLaren KM; Pepper DS
J Clin Pathol; 1982 Nov; 35(11):1227-31. PubMed ID: 6183294
[TBL] [Abstract][Full Text] [Related]
14. Platelet-specific proteins in patients with transient ischemic attacks. (Effects of anti-platelet drugs).
Fabris F; Randi ML; Crociani ME; Manzoni S; Tonin P; De Zanche L; Cella G; Girolami A
Ric Clin Lab; 1983; 13(4):437-42. PubMed ID: 6197742
[TBL] [Abstract][Full Text] [Related]
15. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
[No Abstract] [Full Text] [Related]
16. Plasma beta-thromboglobulins and platelet factor 4 during the normal menstrual cycle.
Motomiya T; Yamazaki H
Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):193-5. PubMed ID: 6171983
[No Abstract] [Full Text] [Related]
17. Does the beta-TG/PF4 ratio have any value?
Arocha-Piñango CL; Ojeda A
Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
[No Abstract] [Full Text] [Related]
18. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
20. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
